Less aggressive therapy reasonable in primary GI mantle cell lymphoma
Primary gastrointestinal (GI) mantle cell lymphoma (MCL) is a rare disease with distinct presentations as compared to secondary GI MCL, a recent study has found. Patients with the primary malignancy tend to receive less aggressive treatment, but nevertheless achieve comparable clinical outcomes.
